Prion diseases — close to effective therapy?-Reference-Cited by-同舟云学术

Prion diseases — close to effective therapy?

Published:2004-10 Issue:10 Volume:3 Page:874-884
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Cashman Neil R.,Caughey Byron

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.nature.com/articles/nrd1525.pdf

Reference162 articles.

1. Will, R. G. et al. A new variant of Creutzfeldt–Jakob disease in the UK. Lancet 347, 921–925 (1996). The first recognition of a surprising zoonosis: bovine spongiform encephalopathy to human beings.

2. Coulthart, M. B. & Cashman, N. R. Variant Creutzfeldt–Jakob disease: a summary of current scientific knowledge in relation to public health. CMAJ 165, 51–58 (2001).

3. Ghani, A. C., Donnelly, C. A., Ferguson, N. M. & Anderson, R. M. Updated projections of future vCJD deaths in the UK. BMC Infect. Dis. 3, 4 (2003).

4. Llewelyn, C. A. et al. G. Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet 363, 417–421 (2004). The second description of blood borne transmission of any human prion disease, on a well-recognized background of iatrogenic transmission through prion-contaminated growth hormone, dura, corneas, and neurosurgical instrumentation.

5. Collins, S. J. et al. Quinacrine does not prolong survival in a murine Creutzfeldt–Jakob disease model. Ann. Neurol. 52, 503–506 (2002).

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclization Scaffolding for Improved Vaccine Immunogen Stability: Application to Tau Protein in Alzheimer’s Disease;Journal of Chemical Information and Modeling;2024-03-01

2. Creutzfeldt–Jakob disease and other prion diseases;Nature Reviews Disease Primers;2024-02-29

3. Potential Therapeutic Use of Stem Cells for Prion Diseases;Cells;2023-10-07

4. Binding modes of potential anti-prion phytochemicals to PrPC structures in silico;Journal of Ayurveda and Integrative Medicine;2023-07

5. Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide “Glycindel” Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson’s Disease;ACS Chemical Neuroscience;2022-07-15